Human CD20 Protein-VLP (CD2-HM122)

  • Express System: HEK293
  • Purity: > 95% as determined by HPLC
  • Activity: Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA (QC Test). See testing image for detail.
  • Exact Sequence: Met1-Pro297

Catalog: CD2-HM122

$1,313.00
Size:

Order now get it on

Bulk Quote | Test Sample
Product Description Recombinant Human CD20 Protein-VLP is expressed from HEK293.It contains Met1-Pro297.
Product Category Recombinant Protein
Target CD20 VLP
Synonyms MS4A1; CD20; MS4A-1; B1; Bp35; CD20 receptor; CD20S7; CVID5; LEU-16; Ly-44; MS4A2; S7
Gene/Protein ID P11836-1
Species Human
Exact Sequence Met1-Pro297
Molecular Weight The target protein has a predicted MW of 34.3 kDa.
Activity Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA (QC Test). See testing image for detail.
Express System HEK293
Purity > 95% as determined by HPLC
Endotoxin Less than 1EU per ug by the LAL method.
Form Liquid
Shipping Shipped with dry ice.
Formulation Supplied as 0.22um filtered solution in PBS (pH 7.4). Notice: If you need it for immunization, Do Not use any adjuvant.
Stability And Storage Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA (QC Test).
Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Ofatumumab, hFc Tag with the EC50 of 2.3ng/ml determined by ELISA (QC Test).
The purity of Human CD20 VLP is greater than 95% as determined by SEC-HPLC.

You may also be interested in

View more associated products